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Abstract Evidence for the extent and nature of atten-
tional impairment in premanifest and manifest Hunting-
ton’s disease (HD) is inconsistent. Understanding such
impairments may help to better understand early functional
changes in HD and could have consequences concerning
care for HD patients. We investigated attentional control in
both early and premanifest HD. We studied 17 early HD
subjects (mean age: 51 years), 12 premanifest HD subjects
(mean age: 43 years), and 15 healthy controls (mean age:
51 years), using the sustained attention to response task
(SART), a simple Go/No-go test reflecting attentional and
inhibitory processes through reaction time (RT) and error
rates. Simultaneously recorded EEG yielded P300 ampli-
tudes and latencies. The early HD group made more Go
errors (p \ 0.001) and reacted slower (p \ 0.005) than the
other groups. The RT pattern during the SART was
remarkably different for early HD subjects compared to the
other two groups (p \ 0.005), apparent as significant post-
error slowing. P300 data showed that for early HD the No-
go amplitude was lower than for the other two groups
(p \ 0.05). Subjects with early HD showed a reduced
capacity to effectively control attention. They proved
unable to resume the task directly after having made an
error, and need more time to return to pre-error perfor-
mance levels. No attentional control deficits were found for
the premanifest HD group.
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Introduction
Huntington’s disease (HD) is an autosomal dominant
neurological disorder characterized by progressive motor,
cognitive and behavioural abnormalities. While the clinical
diagnosis is based on the presence of motor signs, deficits
in the other functional domains are widespread [9, 39]. The
discovery of the HD gene [17] allows gene-carriers to be
identified in the premanifest phase of the disease, i.e.,
before symptoms and signs appear. Deficits in cognition
such as psychomotor slowing, memory decline and exec-
utive dysfunctioning have been reported in both manifest
and premanifest individuals [23], but inconsistently [16].
Attentional processing may well be abnormal in HD, but
results are conflicting: some authors reported attentional
and inhibitory deficits in both patients and premanifest
gene carriers [24, 38], while others did not [42]. The
conflict may be due to the complex nature of the widely
applied neuropsychological tests such as the symbol digit
modalities test, the stroop colour-word task and the trial
making test. These assess attention and inhibition, they also
tap into psychomotor speed, implicit learning, and visuo-
motor integration.
Studies of attentional processing showed deficits in
focused attention [27, 32], shifting attention [2, 8], and
inhibition, with sometimes reduced inhibition [2] and
sometimes increased inhibitory control [1]. Because of
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such methodological differences it is difficult to come to a
conclusion about overall attentional processing in HD.
Moreover, attention and inhibition are functionally very
closely related and rely heavily on each other, i.e. attention
often is a prerequisite of correct inhibition. This interde-
pendence led us to investigate attention and inhibition
together in the context of attentional control, a construct
overarching the two terms [20, 26].
The sustained attention to response test
The sustained attention to response test (SART) is a test of
attention control assessing both attentional and inhibitory
processes [18, 31, 35]. Participants are requested to press a
button when a number (1–9) appears on a screen except
when that number is a three. The need to withhold
responses only to rare stimuli means that the task relies
heavily on attentional control. Pressing a button is simple
in terms of motor control, important in HD, as motor dis-
turbances can interfere with the determination of cognitive
deficits. The SART demonstrated deficiencies in attention,
in disorders such as traumatic brain injury [6], schizo-
phrenia [7], attention deficit hyperactivity disorder [3] and
narcolepsy [15].
The P300
There is a growing need in HD research for sensitive,
objective and quantifiable assessments. Electroencepha-
lography (EEG) has the advantages of low cost, non-
invasiveness and high temporal resolution. Event-related
potentials (ERP) are EEG-based potentials reflecting the
neurophysiologic substrate of mental processes such as
stimulus identification, processing and response initiation
[25]. We focused on the P300 peak, which is most com-
monly evoked by rare stimuli interspersed in a series of
frequent ones. Although the exact neural origin is not
entirely clear, the P300 is often linked with processes of
attention [5, 14, 22]. Some authors have suggested P300
amplitude to reflect the amount of attentional resources
allocated to the stimulus, while the latency is linked to the
stimulus evaluation time, or more general, speed of cog-
nitive processing of the stimulus [30]. In previous work
P300 latency was increased and its amplitude decreased in
manifest HD compared to healthy controls in a visual
search task [28] and a visual Go/No-go task [4]. However,
no P300 abnormalities were found in premanifest HD or
those at risk in auditory odd-ball paradigms [12, 19].
The P300 can be elicited by Go/No-go tasks such as the
SART. Studies in healthy individuals found that simulta-
neous SART and EEG assessment resulted in good indexes
for attentional and inhibitory processes [11]. Only one
previous study has used the combination of SART and
P300 in premanifest HD [21], but found no differences in
P300 characteristics between the premanifest HD group
and controls. They concluded that possibly their premani-
fest group was not yet close enough to disease onset and
that with progressive basal ganglia degeneration closer to
onset differences would have emerged. Indeed, magnetic
resonance imaging measurements of grey and white matter
structures showed changes before the appearance of overt
clinical signs of HD [13, 41].
We hypothesized that both premanifest and manifest
(early) HD groups show impaired attentional control in
comparison with control subjects as measured by a
heightened error rate on the SART. Furthermore, we aim to
further strengthen this hypothesis by showing altered P300
characteristics (i.e. lowered amplitude and increased
latency) in both HD groups in accordance with deviant
SART results. Because of the motor disturbances in HD we




Thirteen subjects with premanifest HD (PMHD), 18 with
early manifest HD (MHD) and 17 age-matched healthy
controls, relatives that were tested as gene-negative, were
included, all were above the age of 18 years. Participants
were recruited from the outpatient neurologic clinic of the
Leiden University Medical Centre and had been genetically
tested for HD. Gene carriers were considered premanifest
when they had five points or less on the total motor sub-
scale of the Unified Huntington’s Disease Rating Scale
(UHDRS) [40]. The manifest group consisted of early HD
subjects (Shoulson–Fahn stages 1 and 2) [34]. Disease
burden was calculated using the formula ‘age (CAG-35.5)’
[29]. Exclusion criteria were major psychiatric disorders,
neurological co-morbidity, a score of B25 on the mini-
mental state examination and medication with known
effects on the EEG (e.g. neuroleptics). The study was
approved by the local medical ethical committee and all
participants gave written informed consent.
All participants underwent neurological, SART and
EEG assessments. Depression was measured using the
short version of the problem behaviour assessment for HD
[10]. The motor part of the UHDRS was administered by a
clinician (SvdB) blinded for genetic status.
One PMHD, one MHD, and one control subject were
excluded because of excessive muscle artefacts on the
EEG. One additional control was excluded because of
epileptiform abnormalities on the EEG. Data of 12 PMHD,
17 MHD and 15 controls were analyzed.
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Sustained attention to response task
For the SART, subjects were seated in a comfortable chair
1 m from a computer screen, with a computer keyboard
placed in easy access of the dominant hand. Numbers from 1
to 9 were shown 25 times on a computer screen. Subjects
were asked to respond to the appearance of every number by
pressing the spacebar (‘Go’ trials), except when the number 3
was shown (‘No-go’ trials). When the number 3 was dis-
played, participants were instructed to withhold their
response. Reaction time (RT) was recorded whenever the
spacebar was pressed. To ensure accurate measurement of
RT a cathode ray screen was used together with a purpose
built hardware device that allowed precise measurement of
the build-up time of the screen information and hence of RT
in relation to the visual stimulus. Subjects were instructed
that accuracy and speed were equally important. Before the
start of the test subjects performed a practice run consisting
of 25 numbers from 1 to 9 in random order. Stimuli were
shown for 250 ms followed by a blank screen for 900 ms
(detailed description of the task see [31]). Outcome measures
for the SART were RT and error rates. ‘Overall RT’ refers to
mean RT over all trials performed. The mean RT for correct
Go trials and incorrect No-go trials were also computed.
Error rate data consisted of overall error rate (the total
number of errors as a percentage of the total number of trials
performed), error rate Go (total of Go errors as percentage of
total number of trials) and error rate No-go (total of No-go
errors as a percentage of total number of trials).
ERP recording and analysis
All EEGs (Nihon Kohden 2110 EEG apparatus) were
recorded between 12.00 and 14.30 h, except for one control
subject tested late in the morning. Twenty-one Ag/AgCl
electrodes were placed according to the 10/20 convention.
ECG, respiration and horizontal eye movement leads were
also recorded. The EEG was band-pass filtered from
0.16–70 Hz before display and analysis. Sample frequency
was 200 Hz and A–D precision 12 bits. For the P300
analysis we used the midline sites Fz (frontal), Cz (central)
and Pz (parietal) with linked mastoids as reference. The
computer controlling the SART paradigm wrote synchro-
nization signals to the EEG machine, allowing averaging to
take place offline after controlling for signal quality. Data
were averaged over epochs of 1200 ms, starting 200 ms
before stimulus onset. Individual trials with eye blink
artefacts or suspected muscle artefacts (peak amplitudes
more than 75 lV) were excluded from P300 analysis. The
P300 component was defined as the maximum positivity
between 350 and 650 ms. This time-frame was based on
visual inspection of the averaged ERPs. ERP analysis,
including peak detection, was performed automatically
using an in-house developed program written in MATLAB
(MathWorks, Natick, USA). Peak amplitudes were mea-
sured relative to a 200 ms baseline before stimulus onset.
Outcome measures consisted of amplitude and latency
data. The mean amplitudes and latencies for all trials, all
Go trials and all No-go trials were calculated averaging the
data from the midline electrodes.
Statistical analysis
SPSS for Windows version 17.0 was used for data analysis.
Analyses of demographic variables were performed using
parametric and non-parametric tests where appropriate.
Group differences for mean SART RT and error rate and
P300 amplitude and latency data were calculated using
univariate analysis of covariance (ANCOVA) with age as a
covariate. Upon visual inspection of the RT patterns for the
four trials preceding and the four trials following a No-go
trial, different patterns were observed. To investigate pos-
sible group differences in these patterns a secondary
analysis was performed. For this purpose the difference
(delta) between the mean RT just before and just after both
correct and incorrect No-go trials was calculated for each
subject. The delta scores for the three groups were ana-
lyzed again using ANCOVA with age as covariate. The
Bonferroni method was used to correct for multiple testing.
The level of significance was set at p B 0.05. P val-
ues [0.05 \ 0.1 were reported as trend significant.
Results
Clinical characteristics
There were no differences between groups for sex, age, IQ
and level of education (Table 1). Disease burden differed








Age (years) 51 (10) 43 (10) 50 (11)
CAG 20 (3) 42 (2) 44 (3)
Male/femalea, b 7/8 6/6 8/9
Level of educationa, b
(lower/middle/higher)
1/9/5 0/9/3 2/11/12
Intelligence Quotient (IQ) 107 (8) 105 (8) 101 (12)
Disease burden 251 (75) 404 (81)
Descriptive statistics are presented as mean (standard deviation),
except for a which is total number. IQ was measured by the National
Adult Reading Test (Dutch version). Disease burden is age (CAG-
35.5)
b Pearson Chi-square test
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significantly between PMHD and MHD (p \ 0.0001). Two
subjects (one premanifest, one early HD subject) were
rated as mildly depressed; depression, however, did not
differ between groups (data not shown in table).
SART
Table 2 shows SART error rate and RT data. The overall
error rate (i.e. all errors made, not differentiated for
type) differed significantly between groups (p \ 0.05)
(Table 2). The MHD group made significantly more
errors of all types than both PMHD and controls
(p \ 0.05). Further analysis revealed that only for Go-
errors (i.e., subjects did not press the spacebar when they
ought to) there was a group difference (p \ 0.001).
Surprisingly, the number of No-go errors (pressing the
spacebar when the number 3 appears) did not differ
between groups. Concerning mean RT (i.e. mean RT for
all pressed trials, not differentiated for correct or erro-
neous trials), there was a group difference (p \ 0.005),
where the overall RT was significantly longer for MHD
than for PMHD (p \ 0.005) and controls (p \ 0.001).
P300
The number of epochs used for P300 analyses were not
different between groups. P300 amplitudes were larger for
No-go trials than Go trials (Table 2; Fig. 1a, b). Overall
P300 amplitude proved only trend significant between
groups (p \ 0.06). Amplitude in No-go trials differed sig-
nificantly between groups, with lower amplitude in MHD
than in the other groups (p \ 0.05). For mean latency only
a trend towards significant group differences for Go trials
was observed (p \ 0.06).
Reaction time patterns before and after correct
and incorrect No-go
Almost all Go errors (not pressing on 1–9) occurred
directly following a No-go error (incorrectly pressing on
3), with MHD making significantly more of these errors
than the PMHD group (p \ 0.05). The RT patterns for the
four trials preceding and following both correct and
incorrect No-go trials are shown in Fig. 2. Analysis of
covariance on the difference between the RT of the last
trial before and the first trial after both correct and incorrect
No-go responses revealed a significant result for incorrect
No-go trials only (p \ 0.01). MHD had a significantly
slower response to the first Go trial following an incorrect
No-go trial compared to controls (p \ 0.005) and PMHD
(p \ 0.05). P300 amplitude did not differ significantly for
trials surrounding correct and incorrect No-go trials.
Discussion
The main finding of this study was that attentional control
is deficient in MHD, evident primarily through a height-
ened error rate on the SART. This behavioural deficit was
corroborated by abnormalities of P300 characteristics.
SART error rate
As expected, MHD made more errors of any type than the
other groups, indicative of defective attentional








Main effect MHD––Controls PMHD––Controls MHD–PMHD
SART
Error rate 4.3 (1.8) 3.9 (2.5) 6.3 (2.8) 0.021 0.027 ns 0.014
Error rate No-go 27.7 (11.9) 25.8 (13.8) 32.9 (15.9) ns ns ns ns
Error rate Go 1.4 (0.98) 1.2 (1.3) 3.0 (1.4) <0.001 0.001 ns 0.001
Mean RT 381 (34) 388 (48) 462 (77) 0.001 < 0.001 ns 0.004
P300
Amplitude 8.7 (2.8) 8.3 (4.4) 5.9 (3.2) 0.058 ns ns ns
Amplitude Go 7.9 (2.8) 7.8 (4.6) 5.4 (3.1) ns ns ns ns
Amplitude No-go 16.3 (4.9) 1.61 (4.5) 1.20 (5.6) 0.046 0.023 ns 0.064
Latency 414 (37) 401 (37) 439 (57) ns ns ns ns
Latency Go 408 (30) 405 (43) 445 (62) 0.059 ns ns ns
Latency No-go 430 (38) 424 (47) 447 (50) ns ns ns ns
Data are mean (standard deviation), Errors are percentage of errors out of total number of stimuli, Amplitude is lV, Latency is milliseconds.
Bold values are statistically significant (p \ 0.05)
RT Reaction time in milliseconds, ns not significant
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mechanisms. Unexpectedly, this was not caused by a high
rate of No-go errors, but by significantly more Go errors.
The only study using the SART in HD did not report about
the type of errors made [21]. Even though they used dif-
ferent Go/No-go paradigms other studies also report on
attentional deficits in manifest HD as measured by more
Go errors for manifest HD compared to controls, but all
have concomitantly also found more No-go errors, contrary
to our findings [27, 36]. Our findings are partly in line with
studies using the SART in other brain disorders with
known attentional deficits. Schizophrenic patients have
also been found to largely make Go errors and not No-go
errors [7]. However, patients with traumatic brain injury
made significantly more errors of both types, with stronger
evidence for No-go than Go errors [3, 31]. So, our findings
cannot be easily attributed to attentional deficits alone as
earlier findings in other studies were not replicated.
Therefore, they were further investigated in reaction time
pattern analyses.
Reaction time patterns surrounding No-go errors
As the SART is likely to provoke No-go errors due to the
repetitive nature of the task and the rarity of No-go stimuli,
we further investigated the significant amount of Go errors
made by the early HD group. Examination of these Go errors
in MHD revealed that most were made directly following a
No-go error. Analysis of the reaction time patterns for trials
directly preceding and following a correct No-go trial (cor-
rectly withholding response to a three) revealed identical
patterns for the three groups, although the MHD group
reacted significantly slower than the PMHD or control
groups. Prior to correct responses to a No-go trial RT was
relatively stable for all three groups. Directly after such a
correctly withheld response, RT was noticeably shorter. This
speeding most likely represents action anticipation that is
evoked by the repetitive nature of the SART. This primes the
motor response; after having correctly withheld the response
at the No-go trial, the response to the next Go trial is more
quickly accessed, resulting in a quicker response [37].
Although the MHD group reacted slower, the general pattern
was the same as for the other groups. This suggests that the
cause of slowing is due to motor disturbances and not to
different cognitive processing.
Interestingly, a different pattern emerged concerning
incorrect No-go responses, i.e. when participants incorrectly
pressed the space bar in response to a 3. For all three groups
the trials directly preceding such a No-go error showed a
shortened RT. We hypothesize that this pre-error speeding
could mean that the task was performed fairly automatically,
with less attentional control, eventually resulting in an error
[31]. Remarkably, this pre-error speeding was more promi-
nent in MHD than in the other two groups. This could indi-
cate that subjects with MHD can sustain attention less well
than the other groups. After such a No-go error RT returned
to the pre-error level almost immediately for the PMHD and
control groups, but not for the MHD group, showing a dra-
matic post-error slowing.
One proposition for this is that a No-go error induces
MHD subjects to slow down in response time in the hope
of making fewer errors. This is an unconscious cognitive
strategy known as ‘speed accuracy trade-off’ (SAT): low
speed allows high accuracy [33]. That healthy controls
performing the SART use this SAT strategy has also been
put forward by Helton and colleagues [18]. At first glance
one would then expect that subjects who choose ‘accuracy
Fig. 1 a Go P300 waves per group (averaged). Note P300 waves for
the three groups during SART Go trials, averaged over the midline
electrodes. Time point 0 denotes the point of stimulus presentation.
b No-go P300 waves per group (averaged). Note P300 waves for the
three groups during SART No-go trials, averaged over the midline
electrodes. Time point 0 denotes the point of stimulus presentation
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over speed’ would make fewer errors, but this was not the
case. A more likely explanation is that there is an intrinsic
deficit of attentional control in MHD. This is seen in the
obvious drop in RT trials preceding an error. This could
possibly reflect a drop in attentional control, in turn causing
the No-go error. The post-error RT pattern shows that the
PMHD and control groups are able to return to the task
immediately and perform on pre-error level. The pattern of
the MHD subjects, however, reflects a difficulty in recov-
ery; it takes this group several trials to return to pre-error
performance. This difficulty could be due to the realization
of having made an error, i.e., the response evaluation,
causes confusion; the subsequent quick return to a Go trial
adds to this confusion, leading to a slower return to pre-
error performance. Alternatively, this post-error slowing
does not reflect cognitive confusion, but could be indicative
of an inability to switch from a No-go to a Go response,
and thus from inhibiting the response to activating it.
Together with the fact that directly following a No-go error
significantly more Go errors are made in the MHD group
than in the other two groups we speculate that attentional
and inhibitory deficits are the probable causes of inade-
quate attentional control in MHD. Adding to this theory of
impaired attentional control we found, on further analysis,
that in the trial directly following a No-go error trial, the
early group made significantly more go-errors (8%) than
both the premanifest (0.5%) and control groups (3%).
Similar results in a task-switch and stop-signal task in
MHD have been reported [2]. Post-error slowing was
interpreted in that study as task-switch cost and a deficit in
the ‘inhibition of the just-performed response’ respectively.
The authors attributed these phenomena to deficient inhi-
bition. These explanations are not mutually exclusive in
that early HD subjects can use the speed accuracy trade-off
strategy to avoid making further errors, but that their
cognitive abilities are deficient and they cannot use this
strategy successfully.
Even though constructs such as attention and inhibition
are not directly measurable and can only be derived from
secondary measurements, we hypothesize that the RT
pattern around No-go errors in the MHD group seems to
reflect a cognitive rather than a motor process as subjects
with early HD are able to respond in the same manner as
PMHD and controls in correctly withheld No-go trials,
albeit slower. This similar pattern for all groups demon-
strates that it is not a No-go trial per se that elicits a deviant
reaction from early subjects. The problem seems to lie
purely in the fact that an error was made.
P300 amplitude and latency
As stated before, P300 amplitude is hypothesized to reflect
the amount of attentional capacity that is being allocated to
a stimulus [30]. If so, then P300 amplitude would be lower
for incorrectly performed No-go trials. This was indeed the
case for the MHD group, confirming a lowered attentional
control during presentation of No-go stimuli. Our findings
correspond well to those of Beste et al. [4] and Jurgens
Fig. 2 RT patterns for trials
before and after correct and
incorrect No-go trial. Note The
reaction time for the four trials
preceding and the four trials
following No-go trails. Data are
separated for RT patterns
surrounding correct responses
(i.e. not pressing at No-go
stimulus) and incorrect
responses (i.e. pressing at No-go
stimulus), averaged per group
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et al. [21]. Mu¨nte et al. [28] also reported lowered P300
amplitude; however, not in the context of a Go/no-go task.
P300 latency is thought to be linked to the speed of
attentional processing [30]. In accordance with Mu¨nte et al.
[28], P300 latency was significantly longer in MHD com-
pared to the other groups for Go trials. This implies a low
speed of attentional processing during Go trials is lessened
for MHD. Together with a lowered attention during No-go
trials this strengthens our hypothesis that the disturbed
pattern observed surrounding No-go errors is of a cognitive
rather than a motor nature.
Premanifest HD results
PMHD did not exhibit any attentional or inhibitory deficits.
Explanations for this are that no attentional control deficits
are yet present or that subtle changes in attentional control
capacity are already present in PMHD, but that they are still
too subtle to be measured with this method. Possibly these
deficits gradually worsen and are better picked up in subjects
closer to expected onset. This interpretation seems plausible
as both SART and P300 data did show a nonsignificant trend
towards worse performance in the premanifest group. The
only reverse pattern concerned SART error rate, where
PMHD subjects made fewer errors than controls. We
hypothesize that this reflects a high motivation. Clinical
experience suggests that PMHD subjects are highly moti-
vated to perform to their best on the tests, as they may wish to
prove that there they are still in the premanifest phase.
Practical implications and limitations
Patients with HD may experience more distress from the
decline of their cognitive functions rather than the presence
of motor disturbances. The results from this study indicate
that patients with HD experience difficulties with recov-
ering after an error and maintaining attentional control for
a longer period, which adds to the knowledge about cog-
nition in HD and could have implication for daily care.
A limitation to the present study is the relative small
number of subjects in the PMHD group and therefore
having less statistical power. This could have obscured
possible subtle differences from controls.
We conclude that there is an attentional control deficit in
MHD. MHD subjects are cognitively not able to directly
resume task requirements after having made an error and
that they need more time to return to pre-error performance
level. No attentional control deficits were found for the
PMHD group.
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